Whitehawk Therapeutics, Inc.

US$3.13As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:WHWKHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (33.53%)
Div yield —
ROE (44.98%)
Biotechnology
Beta (5Y) 0.96
PE TTM —
TSR TTM 30.42%
Mkt cap US$178.4M
ROIC (30.30%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.04
28.99%
(80.66%)
Hold 4|3|7|5|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.04
13.14%
14.35%
14.56%
19.39%
Revenue$M
14.29
14.21
14.85
14.92
0.04%
0.60%
0.65%
4.09%
Peers (US$178.4M)
Cap (US$)
PE
176.9M
—
Capital
TTM
5Y
10Y
Leveragex
1.572
0.271
0.216
EBIT/Intx
0.499
0.225
0.267
Own earn%
91.02
(75.58)
(68.93)
Sh yield%
21.68
45.09
46.07
Owners
Insiders/Inst%
10.67
37.50
Short interest%
0.51
SBC / revenue%
5.23
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
12–18
$1 testx
—
Incr. ROIC%
4